Crinetics Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
43.71
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
3
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.83
|
-0.78
|
0.05
|
6.02%
|
|
2022-06-30
|
-0.67
|
-0.81
|
-0.14
|
-20.90%
|
|
2022-03-31
|
-0.58
|
-0.73
|
-0.15
|
-25.86%
|
|
2021-12-31
|
-0.62
|
-0.68
|
-0.06
|
-9.68%
|
|
2021-09-30
|
-0.72
|
-0.73
|
-0.01
|
-1.39%
|
|
2021-06-30
|
-0.61
|
-0.70
|
-0.09
|
-14.75%
|
|
2021-03-31
|
-0.66
|
-0.69
|
-0.03
|
-4.55%
|
|
2020-12-31
|
-0.58
|
-0.66
|
-0.08
|
-13.79%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.32
|
|
2021-12-31
|
-2.80
|
|
2020-12-31
|
-2.46
|
|
2019-12-31
|
-2.08
|
|
2018-12-31
|
-3.56
|